Why does thalassemia cause splenomegaly?

An enlarged spleen in individuals with beta thalassemia may occur due to increased destruction of red blood cells, the formation of blood cells outside of the bone marrow (extramedullary hematopoiesis), repeated blood transfusions, or iron overload.

Can you live a normal life with thalassemia?

People who have mild or minor forms of thalassemia can typically lead normal lives. In severe cases, heart failure is a possibility. Other complications include liver disease, abnormal skeletal growth, and endocrine issues.

Who is at risk for beta thalassemia?

Beta thalassemia is most often found in people who are of Greek, Italian, African, or Asian origin. The diagnosis is most often made between ages 6 and 12. These tests may be able to tell if you are a carrier and can pass the disorder on to your children: Complete blood count (CBC).

Is milk good for thalassemia?

Many factors in thalassaemia promote calcium depletion. A diet containing adequate calcium (e.g. milk, cheese, dairy products and kale) is always recommended.

What is beta thalassemia?

Learn more Beta thalassemia is a blood disorder that reduces the production of hemoglobin. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body. In people with beta thalassemia, low levels of hemoglobin lead to a lack of oxygen in many parts of the body.

What is beta-thalassemia (β-thalassemia)?

Beta-thalassemia (β-thalassemia) is an autosomal recessive inherited disorder that causes decreased production of hemoglobin. Ineffective erythropoiesis and excess iron deposition are the most significant pathophysiological problems. Chronic red blood cell transfusions along with control of iron overload are the main principles of treatment.

Is thalassemia major dominant or recessive?

Thalassemia major and thalassemia intermedia are inherited in an autosomal recessive pattern, which means both copies of the HBB gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

What are the treatment options for anemia in thalassemic patients?

An alternative way to improve anemia in thalassemic patients is to stimulate HbF production with the use of phosphodiesterase 9 inhibitors, such as IMR-687. This agent has shown encouraging results in sickle cell disease patients and is currently being tested in aduts with TDT and NTDT.